6.6M
U.S women affected
88%
Left untreated
10 min
Procedure time
TRANSFORMING WOMEN'S HEALTH
Revolutionizing Pelvic Organ Prolapse Care
Tissue Lifting & Tensioning (TLT) delivers a minimally invasive, 10-minute solution that restores anatomy without bulky implants or permanent mesh.
10 Minutes
Optimized Procedure Time
Streamlined workflow designed for high-volume outpatient settings.
THE ARCUS TLT SOLUTION
Tissue Lifting & Tensioning REIMAGINED
The Arcus TLT device restores anatomical support through a minimally invasive 10-minute approach. Clinical simplicity paired with strong procedural economics enables a safe transition to in-office or ASC settings.
3 Steps
Simplicity & Repeatability
Access, capture, and fixation,
Anatomical Restoration without mesh
The Arcus TLT approach restores pelvic support using the body's own tissue - eliminating the erosion risks, complications, and long-term consequences associated with permanent mesh implants
THE ARCUS TLT SOLUTION
Tissue Lifting & Tensioning REIMAGINED
The Arcus TLT device restores anatomical support through a minimally invasive 10-minute approach. Clinical simplicity paired with strong procedural economics enables a safe transition to in-office or ASC settings.
Anatomical Restoration with no mesh
The Arcus TLT approach restores pelvic support using the body's own tissue - eliminating the erosion risks, complications, and long-term consequences associated with permanent mesh implants
View Technology
10 Minutes
Optimized Procedure Time
Streamlined workflow designed for high-volume outpatient settings
3 Steps
Simplicity & Repeatability
Access, capture, and fixation
0 Mesh
No Permanent Mesh
Anatomy restored without bulky implants, reducing long-term complication risk.
The perfect storm of market need, regulatory opportunity, and clinical demand
WHY NOW?
Massive Unmet Need
6.6M U.S. women suffer from POP; 88% remain untreated due to lack of minimally invasive options.
FDA Created Vacuum
Removal of transvaginal mesh opened a gap for safer, office-based innovation.
Immediate Reimbursement
Existing CPT codes (57240/50/60) enable reimbursement from day one.
Office-Based Care
No modern office or ASC solution exists today. Arcus fills the gap.
Arcus Medical is positioned for rapid adoption as surgeons seek minimally invasive alternatives to transvaginal mesh.
Patented simplicity for rapid adoption and consistent outcomes
1
Minimally invasive access to the treatment area through a precise, controlled approach.
Access
2
Proprietary mechanism captures and positions prolapsed tissue with controlled tension.
Capture
The TLT 3-Step Process
3
Fixate
Secure fixation restores normal anatomy and provides durable support.
TLT restores normal pelvic anatomy without synthetic mesh
Anatomical Restoration
Massive Market Opportunity
Everyone serves the 12% — we serve the 88%
150M
Total addressable market
Women globally affected by pelvic organ prolapse.
6.6M
Serviceable addressable market
U.S. women seeking treatment options.
5.8M
Serviceable obtainable market
Untreated women — the primary 88% segment.
Investment Highlights
Raising $1.5M seed to complete trials, regulatory prep, and early commercialization